Trials and Research

Clinical Trials

Glioblastoma Completed

CABARET

A randomised phase II study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme

Primary malignant brain tumour, brain metastases or advanced cancer Completed

SEED

Self-reported evaluation of the adverse effects of dexamethasone

Glioma (G3) and Glioblastoma Completed

ACED

Acetazolamide plus Dexamethasone versus dexamethasone alone in recurrent and/or progressive HGG

Glioma (G2 and G3) Completed

LUMOS

Low & Intermediate Grade Glioma Umbrella Study of Molecular Guided Therapies

Glioma (G3) Completed

CATNON

Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial

Glioblastoma Completed

NUTMEG

A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide alone in newly diagnosed Elderly patients with Glioblastoma

Glioblastoma In Follow-Up

MAGMA

The Multi-Arm GlioblastoMa Australasia (MAGMA) Trial

Medulloblastoma Closed

PersoMed-I

Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I)

Relapsed Grade 2/3 IDH-mutant glioma Open

LUMOS2

Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided Therapies

Glioblastoma Completed

VERTU

A Randomised Phase II study of Veliparib, Radiotherapy and Temozolomide in patients with unmethylated O (6)-methylguanine-DNA methyltransferase (MGMT) Glioblastoma